相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
O. Huillard et al.
BRITISH JOURNAL OF CANCER (2013)
Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
Marie-Helene Massicotte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
Jennifer Wheler et al.
CLINICAL CANCER RESEARCH (2012)
Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia
A. V. Khamoui et al.
EUROPEAN JOURNAL OF CANCER CARE (2012)
Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors
David Olmos et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy
Noelle K. LoConte et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Benjamin H. L. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
M. L. Telli et al.
ANNALS OF ONCOLOGY (2008)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
A. Italiano et al.
ANNALS OF ONCOLOGY (2008)
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2007)
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: Findings from intergroup trial 0114
JA Meyerhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Relationships between body composition parameters and fluorouracil pharmacokinetics
M Gusella et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
分享论文
